Previous close | 2.2000 |
Open | 2.2700 |
Bid | 2.3000 x 800 |
Ask | 2.3600 x 1000 |
Day's range | 2.2001 - 2.4300 |
52-week range | 1.5600 - 10.9400 |
Volume | |
Avg. volume | 1,052,985 |
Market cap | 110.215M |
Beta (5Y monthly) | -0.08 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.3100 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.00 |
NATICK, Mass., May 02, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO-EC) held in Vienna, Austria on 2-4 May 2024.
NATICK, Mass., April 30, 2024--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary, unaudited results for the first quarter 2024. Management expects preliminary unaudited results for the period as follows:
NATICK, Mass., April 17, 2024--Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments